Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

Overview of attention for article published in International Journal of Retina and Vitreous , March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

dexamethasone intravitreal implant

Cited by Canadian Agency for Drugs and Technologies in Health on 04 May 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Dexamethasone Intravitreal Implant for Macular Edema Following Central Retinal Vein Occlusion

Cited by Canadian Agency for Drugs and Technologies in Health on 07 Jul 2022

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.